| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 16,739 | 15,507 | 16,037 | 17,383 | | Cost of Revenue | 7,124 | 6,935 | 6,755 | 14,268 | | | Gross Profit | 9,615 | 8,572 | 9,282 | 3,115 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| 754 | | Selling General and Administrative | 9,155 | 8,182 | 8,878 | 8,907 | | Non Recurring |
-
|
-
|
-
| 76,178 | | Others | 213 | 214 | 213 | 387 | | | | Total Operating Expenses |
-
|
-
|
-
| 86,226 | | | | Operating Income or Loss | 247 | 176 | 191 | (83,111) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (63) | (53) | 68 | 366 | | Earnings Before Interest And Taxes | 184 | 123 | 259 | (82,745) | | Interest Expense |
-
|
-
|
-
| 300 | | Income Before Tax | 184 | 123 | 259 | (83,045) | | Income Tax Expense |
-
|
-
|
-
| (3,593) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 184 | 123 | 259 | (79,452) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 184 | 123 | 259 | (79,452) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $184 | $123 | $259 | ($79,452) |
|
0.11% Nasdaq 
0.01%
Income Statement
